{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fraising-cannabis-capital.simplecast.com%2Fepisodes%2F0264-clever-leaves-kyle-detwiler-J5yjsxks","width":444,"version":"1.0","type":"rich","title":"Clever Leaves | Kyle Detwiler","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/bf0c0aa3-a8f6-466d-ae86-ebecc41ae726/3398d989-789c-44d1-8b42-7c4a1c1570a3/raising-cannabis-capital-clever-leaves-2-artwork-s.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/e7390a66-a7c8-4091-bded-db60f68e6b36\" height=\"200\" width=\"100%\" title=\"Clever Leaves | Kyle Detwiler\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Publicly traded cannabis pharmaceutical preparations company\n\nThe need for cannabis companies to become more specialized continues to increase as the industry evolves.   Kyle  Detwiler, Clever Leaves CEO is back to update Dan Humiston  on their growing global enterprise and to explain why their focus on cannabis pharmaceutical preparations positions them for future pharmaceutical partnerships.\n\nProduced By podCONX"}